The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The fragile X prevalence paradox
Open accessAbstract
Although fragile X syndrome (FXS; OMIM 300624) is generally regarded as the most common inherited form of cognitive impairment,1–3 there is little consensus as to its prevalence in the general population or to sex-specific differences in prevalence. Estimates of FXS prevalence (∼1/4000–1/8000) that are based on population projections from cohorts of children with special education needs (SEN) generally underestimate the extent of clinical involvement (for a comprehensive summary, see Song et al 4), as many individuals affected by the behavioural, emotional and/or learning disabilities of FXS have IQs in the normal or borderline range.5 6 The latter may not be included in cohorts that use cognitive impairment as an inclusion criterion, a problem that is particularly marked for girls, with the majority having IQs within the normal range.7 A second difficulty with population studies is the tendency to conflate disease prevalence (projections from SEN cohorts) with allele/carrier frequencies within the general population, as prevalence estimates will only approach carrier frequencies for complete penetrance. Thus, seemingly paradoxical results among studies of prevalence may reflect the effects of selection bias, conflation and differing defining criteria for FXS across studies. Aspects of this “paradox” are exemplified by two important screening studies of Israeli women. Using the same cut-off point (55 CGG repeats) for premutation (PM) carriers, Toledano-Alhadef et al 8 found a higher frequency of carriers (127/14 334 = 1/113) than did Pesso et al 9 (62/9459 = 1/152), despite the fact that Pesso et al reported a higher frequency for full mutation (FM) alleles (4 FM carriers; 1/2365) than did Toledano-Alhadef et al (3 FM carriers; 1/4778). Although the numbers of FM alleles in the two studies are too small to attach significance to the difference in frequencies, the trend is consistent with the exclusion of individuals with a family history of …
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Catalogue of Unbalanced Chromosome Aberrations in Man
Schinzel, A. (1983) · De Gruyter eBooks · doi:10.1515/9783112329047 · Cited by 758
Many sequence variants affecting diversity of adult human height
Gudbjartsson, D. F., Walters, G. B., Thorleifsson, G., Stefansson, H., Halldorsson, B. V., Zusmanovich, P., Sulem, P., Thorlacius, S., Gylfason, A., Steinberg, S., et al. (2008) · Nature Genetics · doi:10.1038/ng.122 · Cited by 666
Expansion of the Fragile X CGG Repeat in Females with Premutation or Intermediate Alleles
Nolin, S. L., Brown, W. T., Glicksman, A., Houck, Jr., Gargano, A. D., Sullivan, A., Biancalana, V., Bröndum-Nielsen, K., Hjalgrim, H., Holinski-Feder, E., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367713 · Cited by 421
Rousseau, F., Rouillard, P., Morel, M. L., Khandjian, E. W., & Morgan, K. (1995) · Europe PMC (PubMed Central) · Cited by 361
Tassone, F., Pan, R., Amiri, K., Taylor, A. K., & Hagerman, P. J. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070073 · Cited by 350
Self-citationFragile X‐associated tremor/ataxia syndrome: Clinical features, genetics, and testing guidelines
Berry‐Kravis, E., Abrams, L., Coffey, S. M., Hall, D. A., Greco, C., Gane, L. W., Grigsby, J., Bourgeois, J. A., Finucane, B., Jacquemont, S., et al. (2007) · Movement Disorders · doi:10.1002/mds.21493 · Cited by 331
Self-citationDoes ?ring syndrome? exist? An analysis of 207 case reports on patients with a ring autosome
Kosztol�nyi, G. (1987) · Human Genetics · doi:10.1007/bf00591082 · Cited by 319
Dombrowski, C. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.4.371 · Cited by 289
Fragile-X Carrier Screening and the Prevalence of Premutation and Full-Mutation Carriers in Israel
Toledano-Alhadef, H., Basel-Vanagaite, L., Magal, N., Davidov, B., Ehrlich, S., Drasinover, V., Taub, E., Halpern, G. J., Ginott, N., & Shohat, M. (2001) · The American Journal of Human Genetics · doi:10.1086/321974 · Cited by 228
Mental status of females with an FMR1 gene full mutation.
de Vries, B. B., Wiegers, A. M., Smits, A., Mohkamsing, S., Duivenvoorden, H. J., Fryns, J. P., Curfs, L., Halley, D. J. J., Oostra, B. A., van den Ouweland, A. M., et al. (1996) · PubMed Central · Cited by 206
Cited by
Advances in the Treatment of Fragile X Syndrome
Hagerman, R. J., Berry-Kravis, E., Kaufmann, W. E., Ono, M. Y., Tartaglia, N., Lachiewicz, A., Kronk, R., Delahunty, C., Hessl, D., Visootsak, J., et al. (2009) · Pediatrics · doi:10.1542/peds.2008-0317 · Cited by 596
Epidemiology of fragile X syndrome: A systematic review and meta‐analysis
Hunter, J., Rivero‐Arias, O., Angelov, A., Kim, E., Fotheringham, I., & Leal, J. (2014) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36511 · Cited by 442
A pilot open label, single dose trial of fenobam in adults with fragile X syndrome
Berry-Kravis, E., Hessl, D., Coffey, S., Hervey, C., Schneider, A., Yuhas, J., Hutchison, J., Snape, M., Tranfaglia, M., Nguyen, D. V., et al. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.063701 · Cited by 411
The attentive brain: insights from developmental cognitive neuroscience
Amso, D., & Scerif, G. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn4025 · Cited by 332
Cordeiro, L., Ballinger, E., Hagerman, R., & Hessl, D. (2011) · Journal of Neurodevelopmental Disorders · doi:10.1007/s11689-010-9067-y · Cited by 316
Metadata
- Authors
- Hagerman, P. J.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2008-04-15
- Volume
- 45
- Issue
- 8
- Pages
- 498-499
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2117874342
- Cited by
- 342
- References
- 20
- FWCI
- 17.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The fragile X prevalence paradox. https://app.cochat.ai/papers/10.1136/jmg.2008.059055
- The paper
- Hagerman, P. J. (2008). The fragile X prevalence paradox. Journal of Medical Genetics. https://doi.org/10.1136/jmg.2008.059055
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.